Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Andress

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
The American Journal of Physiology|December 31, 1997
Plasmin degradation of insulin-like growth factor-binding protein-5 (IGFBP-5): regulation by IGFBP-5-(201-218)P G Campbell, D L Andress
The American Journal of Physiology|December 31, 1997
Insulin-like growth factor (IGF)-binding protein-5-(201-218) region regulates hydroxyapatite and IGF-I bindingP G Campbell, D L Andress
The Journal of Biological Chemistry|November 5, 1992
Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF actionD L Andress, R S Birnbaum
Advances in Internal Medicine|January 1, 1989
Aluminum-related osteodystrophyD J Sherrard, D L Andress
Southern Medical Journal|June 1, 1982
Treatment of refractory hypophosphatemiaD L Andress, J B Vannatta, R Whang
Kidney International|May 1, 1991
Identification of a low molecular weight inhibitor of osteoblast mitogenesis in uremic plasmaD L Andress, G A Howard, R S Birnbaum
Kidney International|February 7, 1998
A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communicationJ E Antonsen, D J Sherrard, D L Andress
The American Journal of Medicine|July 1, 1985
Pseudohyperparathyroidism. Syndrome associated with aluminum intoxication in patients with renal failureD J Sherrard, S M Ott, D L Andress
The American Journal of Physiology|January 22, 1998
Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migrationC K Abrass, A K Berfield, D L Andress
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1986
Bone oxalate in a long-term hemodialysis patient who ingested high doses of vitamin CS M Ott, D L Andress, D J Sherrard
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
The American Journal of Physiology|December 31, 1997
Plasmin degradation of insulin-like growth factor-binding protein-5 (IGFBP-5): regulation by IGFBP-5-(201-218)P G Campbell, D L Andress
The American Journal of Physiology|December 31, 1997
Insulin-like growth factor (IGF)-binding protein-5-(201-218) region regulates hydroxyapatite and IGF-I bindingP G Campbell, D L Andress
The Journal of Biological Chemistry|November 5, 1992
Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF actionD L Andress, R S Birnbaum
Advances in Internal Medicine|January 1, 1989
Aluminum-related osteodystrophyD J Sherrard, D L Andress
Southern Medical Journal|June 1, 1982
Treatment of refractory hypophosphatemiaD L Andress, J B Vannatta, R Whang
Kidney International|May 1, 1991
Identification of a low molecular weight inhibitor of osteoblast mitogenesis in uremic plasmaD L Andress, G A Howard, R S Birnbaum
Kidney International|February 7, 1998
A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communicationJ E Antonsen, D J Sherrard, D L Andress
The American Journal of Medicine|July 1, 1985
Pseudohyperparathyroidism. Syndrome associated with aluminum intoxication in patients with renal failureD J Sherrard, S M Ott, D L Andress
The American Journal of Physiology|January 22, 1998
Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migrationC K Abrass, A K Berfield, D L Andress
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1986
Bone oxalate in a long-term hemodialysis patient who ingested high doses of vitamin CS M Ott, D L Andress, D J Sherrard
Pageof 6